INS and type 2 diabetes mellitus: The IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE) study demonstrated that CGM usage improved glycated haemoglobin (HbA1c) reduction of 0.3% (3 mmol/mol), increased time in range by 9.9% (or 2.4 h/day) and decreased time above range by 8.1% (or 1.9 h/day) for people with type 2 diabetes using non-insulin therapies [20].